Kroep JR - Search Results

1

Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.

de Groot S, Lugtenberg RT, Cohen D, Welters MJP, Ehsan I, Vreeswijk MPG, Smit VTHBM, de Graaf H, Heijns JB, Portielje JEA, van de Wouw AJ, Imholz ALT, Kessels LW, Vrijaldenhoven S, Baars A, Kranenbarg EM, Carpentier MD, Putter H, van der Hoeven JJM, Nortier JWR, Longo VD, Pijl H, Kroep JR; Dutch Breast Cancer Research Group (BOOG). de Groot S, et al. Among authors: kroep jr. Nat Commun. 2020 Jun 23;11(1):3083. doi: 10.1038/s41467-020-16138-3. Nat Commun. 2020. PMID: 32576828 Free PMC article. Clinical Trial.

2

[Long-term beneficial effects of cetuximab in a woman with metastasised rectal carcinoma without expression of the epidermal growth factor receptor].

Kroep JR, Gelderblom H, Collen AF, Nortier JW. Kroep JR, et al. Ned Tijdschr Geneeskd. 2006 Nov 18;150(46):2555-9. Ned Tijdschr Geneeskd. 2006. PMID: 17152334 Dutch.

3

[Fertility preservation in female oncology patients].

Jenninga E, Kroep JR, Hilders CG, Louwé LA, Verburg HJ, Nortier JW. Jenninga E, et al. Among authors: kroep jr. Ned Tijdschr Geneeskd. 2008 Nov 8;152(45):2437-41. Ned Tijdschr Geneeskd. 2008. PMID: 19051792 Dutch.

4

Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer.

Kroep JR, Linn SC, Boven E, Bloemendal HJ, Baas J, Mandjes IA, van den Bosch J, Smit WM, de Graaf H, Schröder CP, Vermeulen GJ, Hop WC, Nortier JW. Kroep JR, et al. Neth J Med. 2010 Sep;68(9):371-6. Neth J Med. 2010. PMID: 20876920 Free article.

5

Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer.

van de Ven S, Smit VT, Dekker TJ, Nortier JW, Kroep JR. van de Ven S, et al. Among authors: kroep jr. Cancer Treat Rev. 2011 Oct;37(6):422-30. doi: 10.1016/j.ctrv.2010.11.006. Epub 2010 Dec 21. Cancer Treat Rev. 2011. PMID: 21177040 Review.

6

Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer.

Dijkgraaf EM, Welters MJ, Nortier JW, van der Burg SH, Kroep JR. Dijkgraaf EM, et al. Among authors: kroep jr. Curr Pharm Des. 2012;18(25):3816-27. doi: 10.2174/138161212802002797. Curr Pharm Des. 2012. PMID: 22591418 Review.

7

The role of bevacizumab in advanced epithelial ovarian cancer.

Kroep JR, Nortier JW. Kroep JR, et al. Curr Pharm Des. 2012;18(25):3775-83. doi: 10.2174/138161212802002689. Curr Pharm Des. 2012. PMID: 22591420

8

Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach.

Dekker TJ, Borg ST, Hooijer GK, Meijer SL, Wesseling J, Boers JE, Schuuring E, Bart J, van Gorp J, Mesker WE, Kroep JR, Smit VT, van de Vijver MJ. Dekker TJ, et al. Among authors: kroep jr. Breast Cancer Res. 2012 Jun 13;14(3):R93. doi: 10.1186/bcr3208. Breast Cancer Res. 2012. PMID: 22694844 Free PMC article.

9

The prognostic role of TGF-β signaling pathway in breast cancer patients.

de Kruijf EM, Dekker TJA, Hawinkels LJAC, Putter H, Smit VTHBM, Kroep JR, Kuppen PJK, van de Velde CJH, Ten Dijke P, Tollenaar RAEM, Mesker WE. de Kruijf EM, et al. Among authors: kroep jr. Ann Oncol. 2013 Feb;24(2):384-390. doi: 10.1093/annonc/mds333. Epub 2012 Sep 28. Ann Oncol. 2013. PMID: 23022998 Free article.

10

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.

Dekker TJ, Smit VT, Hooijer GK, Van de Vijver MJ, Mesker WE, Tollenaar RA, Nortier JW, Kroep JR. Dekker TJ, et al. Among authors: kroep jr. Ann Oncol. 2013 Apr;24(4):931-7. doi: 10.1093/annonc/mds599. Epub 2012 Dec 4. Ann Oncol. 2013. PMID: 23211940 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

193 results

Search Page